BIBLIOGRAFIA
1. Vollard EJ, Clasener HAL.
Colonization resistance. Antimicrob. Agents Chemother
1994; 38: 409-414.
2. de la Cal MA, Cerdá E, Garcia
Hierro P. Classification of micro-organisms according to
their pathogenicity. In: van Saene HKF, de la Cal MA and
Silvestri L, (Eds) Infection control in the Intensive
Care Unit. Ed. Springer Milano-Berlin 1998. pp9-16.
3. Bonten MJM, Kullberg BJ, van Dalen
R, et al. Selective digestive decontamination in
patients in intensive care. J Antimicrob Chemother 2000;
46: 351-362.
4. Liberati A, D´Amico R, Pifferi S,
Torri V, Brazzi L. Antibiotic prophylaxis to reduce
respiratory tract infections and mortality in adults
receiving intensive care. Cochrane Database Syst Rev.
2004;(1): CD000022.
5. Silvestri L, van Saene HK,
Milanese M, Gregori D. Impact of selective
decontamination of the digestive tract on fungal
carriage and infection: systematic review of randomized
controlled trials. Intensive Care Med. 2005;31:898-910.
6. León C, Ruiz-Santana S, Saavedra
P. A bedside scoring system (“Candida score”) for early
antifungal treatment in nonneutropenic critically ill
patients with Candida colonization. Critical Care Med.
2006, Vol. 34, No. 3, pp 730-737.
7. Pfaller M, Jones R, Doern G, Sader
H, Hollis R, Messer S For The Sentry Participant Group.
International surveillance of bloodstream infections due
to Candida species: Frequency of occurrence and
antifungal susceptibilities of isolates collected in
1997 in the United States, Canada and South America for
the SENTRY program. J. Clin. Microbiol. 1998; 36: 1886-9
8. de Smet A, Kluytmans J, Cooper.
Decontamination of the Digestive Tract and Oropharynx in
ICU Patients. N Engl J Med 2009;360:20-31.
9. Gøtzsche PC, Johansen HK. Routine
versus selective antifungal administration for control
of fungal infections in patients with cancer (Cochrane
Review). In: The Cochrane Database of Systematic
Reviews, 2, 2002. Chicester, UK: John Wiley & Sons, Ltd.
CD000026.
10. Playford EG, Webster, AC, Sorrell
TC, Craig JC. Antifungal agents for preventing fungal
infections in solid organ transplant recipients. In: The
Cochrane Database of Systematic Reviews, 2, 2004.
Chicester, UK: John Wiley & Sons, Ltd. CD004291.
11. McGowan J. Antimicrobial
resistance in hospital organisms and its relation to
antibiotic use. Reviews in Infectious Diseases
1983;5:1033-48. 6318289.
12. Ostrosky-Zeichner L. New
approaches to the risk of Candida in the intensive care
unit. Current Opinion in Infectious Diseases
2003;16:533-7. 14624102.
13. Wisplinghoff H, Bischoff T,
Tallen SM, et al: Nosocomial bloodstream infections in
US hospitals: Analysis of 24 179 cases from a
prospective nationwide surveillance study. Clin Infect
Dis. 2004; 39:309-317.
14. Wey SB, Mori M, Pfaller MA, et
al: Candidemia in a tertiary care hospital:
Epidemiology, risk factors and predictors of mortality.
Clin Infect Dis 1992; 15:414-421.
15. Pittet D, Monod M, Suter PM, et
al: Candida colonization and subsequent infections in
critically ill surgical patients. Ann Surg 1994; 220:
751-758.
16. Voss A, Hollis RJ, Pfaller MA, et
al, investigation of the sequence of colonization and
candidemia in nonneutropenic patients. J Clin Microbiol
1994; 32:975-980.
17. Pamela A, Lipsett, MD, Surgical
critical care: Fungal infections in surgical patients.
Crit Care Med 2006 Vol 34; 9: 215-224
18. Eggimann P, Garbino J, Pittet D:
Epidemiology of Candida species infection in critically
ill non-immunosuppressed patients. Lancet Infect Dis
2003; 3:685-702.
19. Ostrosky-Zeichner L: Prophylaxis
and treatment of invasive candidiasis in the intensive
care setting. Eur J. Clin Microbiol Infect Dis 2004; 23:
739-744.
20. Kauffman CA, Vazquez JA, Sobel
JD, et al: Prospective multicenter surveillance study of
funguria in hospitalized patients. Clin Infect Dis 2000;
30: 14-18.
21. Pappas PG, Rex JH Sobel JD, et
al: Guidelines for treatment of candidiasis. Clin Infect
Dis 2004; 38:161-189.
22. Rex JH, Sobel JD, Prophylactic
antifungal therapy in the intensive care unit.
Clin Infect Dis 2001; 32: 1191-1200.
23. Alvarez-Lerma F. Epidemiología de la
infección en el paciente crítico. Infecciones fúngicas
en pacientes críticos. Madrid. Ergon. 2002. 7-22
24. Alvar Net. Jordi B. Antoni. SEPSIS
EN EL PACIENTE CRÍTICO. Ars Médica. Barcelona. 2006.
65-78
25. Olivier JW,
van Ruler O., LammeB., Weber RJP, Reitsma B, Boermeester
MA. Single-drug therapy or selective
decontamination of the digestive tract as antifungal
prophylaxis in critically ill patients: A systematic
Review. Crit Care 2007;11
